chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Pt received Afluria Quad immunization. Following day reported to pharmacy with phone call stating that she developed severe lymph node swelling, fever, nausea, diarrhea, and excess sweating, headache - states perfectly fine when getting shot. Hit her all at once.
24 hrs p/vax exp weakness of the lower extremities for 48 hrs; no fever other noticable complaints x/numbness in legs;
A sore arm; She started her period 7 or 8 days early; This spontaneous case was reported by a consumer and describes the occurrence of MENSTRUATION IRREGULAR (She started her period 7 or 8 days early) and PAIN IN EXTREMITY (A sore arm) in a 45-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension. Concomitant products included PROPRANOLOL (PROPANOLOL [PROPRANOLOL]), LORAZEPAM (ATIVAN) and OMEPRAZOLE for an unknown indication.    On 27-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 29-Mar-2021, the patient experienced MENSTRUATION IRREGULAR (She started her period 7 or 8 days early). On an unknown date, the patient experienced PAIN IN EXTREMITY (A sore arm). At the time of the report, MENSTRUATION IRREGULAR (She started her period 7 or 8 days early) and PAIN IN EXTREMITY (A sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was reported. In concomitant medications blood pressure pills was reported.
About 16 hours after receiving my second dose of the covid vaccine I began to have chills, muscle aches, headache and fever of 100.8.
Was given Twinrix Hep A/Hep B to early, not 18 yrs old yet. No reaction stayed at clinic for 20 min.
Redness to (L) thigh. Supportive therapy - ice, ibuprofen, BENADRYL. RTC if worsening symptoms.
Fever, chills first night;  dizziness, joint aches, headache, weakness next day; weakness, joint aches, dizziness into second day. Took Tylenol, drank plenty fluids.
devel 100+/- vesicles filled w/amber/tan fluid, itchy,over 33 days starting 17JUL98 late afternoon;h/a, fatigue, photophobia, afeb;no tx, lesions cleared p/9-10 days;
Patient had severe chills and fever when she went to bed. She also noted a very strong bruise feeling and saying it is extremely painful at injection site. In a 3" circle around the injection site, there is a dark red mark and bruising. Patient was advised to take Benadryl and Tylenol and to go to the emergency room if she has any trouble breathing or if symptoms become emergent.
A 16-year-old patient was at the office with her mom. We completed a COVID-19 vaccine clinic and had 2 doses of the COVID-19 vaccine left (that were not used). Provider asked patient's mom if they wanted the vaccines. The mom and patient were eager to say yes. Provider requested the nurse give the vaccines to the mom and patient. Vaccine given with no concerns at clinic. No phone calls from patient or parent that there were any adverse side effects of either vaccine.
lingering headache that comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (lingering headache that comes and goes) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 31-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Mar-2021, the patient experienced HEADACHE (lingering headache that comes and goes). At the time of the report, HEADACHE (lingering headache that comes and goes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No relevant concomitant medications reported. No treatment information was provided.
Developed left sided facial droop on afternoon of 3/1/2021.  was seen  clinic internal medicine.   Diagnosed with probable Bell's Palsy at outpt clinic prior to  CT and MRI, treated with prednisone taper and valcyclovir. Pt scheduled for 2nd covid vaccine on 3/5/2021
Diarrhea; Headache; Nausea; A spontaneous report from a consumer concerning a 79-year-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced events diarrhea, headache, nausea.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 11 Feb 2021, prior to the onset of the events the patient received their first of two planned doses of mRNA-1273 (lot/batch: 013M20A) intramuscularly for prophylaxis of COVID-19 infection.  On unknown date the patient experienced diarrhea, headache, nausea. Treatment details were not reported.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of events, diarrhea, headache,nausea was unknown.; Reporter's Comments: Based on the current available information and temporal association between the use of the product and the onset date of the reported events, a causal relationship cannot be excluded.
No additional AE reported.; expired GARDASIL 9 that had inadvertently been administered to one patient today 1/18/2023.; This spontaneous report was received from an office manager and refers to a patient of unknown age and gender.  The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 18-JAN-2023, the patient was inadvertently vaccinated with an expiry dose of hpv rl1 6 11 16 18 31 33 45 52 58 vlp vaccine (yeast) (GARDASIL 9) injection  (lot number 1691180 was verified to be a valid number, expiration date reported and established as 15-NOV-2022) administered for prophylaxis (dose, vaccination scheme, strength, and route of administration were not provided) (expired product administered). It was reported that the product was stored according to prescribing information through the date of administration. No additional adverse event were reported.
Rash at injection site that is endurated, erythemic, and warm to touch.
Patient was administered 2nd dose of Pfizer COVID-19 vaccine, 0.3mL, IM. Instructed to wait in lobby for 15 minutes. Approximately 10 minutes after vaccine administration, patient stated that they felt dizzy, stuffy, had throat pain, and had an itchy throat. Immunization nurse notified and responded. Vitals taken at 0955 BP 95/62 supine position, pulse 76, O2 sat 98%, temp 98.7 F. Declared medical emergency via overhead announcement at 0956. Doctor lead team upon response. No epinephrine or dyphenhydramine administered. vitals reassessed at 1002, BP 109/78. Patient was moved to treatment room for further observation. Doctor said patient was stable and scheduled for release of her own accord at approximately 1100, given Sick in Quarters status, and with a follow-up telephone consult scheduled for tomorrow, 07/10/2021.
COVID-19; This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (COVID-19) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced COVID-19 (COVID-19). At the time of the report, COVID-19 (COVID-19) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, SARS-CoV-1 test: probably false positive probably false Positive.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No Concomitant drug information was provided by reporter.  No Treatment drug information was provided by reporter.  The reporter informed that had Covid in the very beginning and it was barely a cold but tested positive. It was probably a false positive  Company Comment:  This is a spontaneous case concerning  a  patient of unknown age and gender, with no reported medical history, who experienced the unexpected non-serious AESI event of Covid-19. The event occurred on an unknow day after the unspecified dose of mRNA-1273 COVID 19 Vaccine. The event outcome were reported as unknown. No further medical information was available. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.; Sender's Comments: This is a spontaneous case concerning  a  patient of unknown age and gender, with no reported medical history, who experienced the unexpected non-serious AESI event of Covid-19. The event occurred on an unknow day after the unspecified dose of mRNA-1273 COVID 19 Vaccine. The event outcome were reported as unknown. No further medical information was available. The benefit-risk relationship of mRNA-1273 COVID 19 Vaccine, is not affected by this report.
The patient reported she had hepatitis A/she almost died/Her liver results still not normal; The patient stated that she had a headache; This spontaneous report has been received from a female consumer of unknown age regarding on herself. There was no information provided about the patient's concurrent conditions, concomitant therapies, historical drugs, drug reactions or allergies, or pertinent medical history.  On an unspecified date, the patient was vaccinated with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) injection, route of administration reported as in the arm, to prevent Hepatitis B (strength, dosage, anatomical site of vaccination, vaccination scheme frequency, lot number, and expiration date were not reported).   On an unspecified date in April 2020, the patient experienced a headache which was treated with acetaminophen (TYLENOL) and hepatitis A. The patient reported that she did not know that she had hepatitis A and that she almost died due to the event. The patient sought for medical attention and was hospitalized for a period of 4 days due to the event. Furthermore, it was reported that the patient had routine laboratory work since being discharged.    The outcome of the events was reported as recovering however, she stated that her liver results were still not normal.  The causal relationship between vaccination with Hepatitis B Vaccine (Recombinant) (RECOMBIVAX HB) and the events occurrence was not provided. The event hepatitis A was considered to be a life-threatening event.
4 days after the vaccine I started feeling very out of it, couldn't concentrate, very fatigued. These effects are still going.
Patient was given a 5-11 yr COVID vaccine instead of 6mon-4yr. Dr. called hospital ID department for guidance. Was told to monitor patient and not repeat dose.
3-1/2 BY 3-1/2 AREA THAT WAS WARM TO TOUCH WITH REDNESS AND HARD AS A ROCK. ARM SORE DAY PRIOR YET SYMPTOMS STARTED ON THE 10TH.
rapid Heart beat; difficulty breathing; dizziness; This spontaneous case was reported by a consumer and describes the occurrence of HEART RATE INCREASED (rapid Heart beat), DYSPNOEA (difficulty breathing) and DIZZINESS (dizziness) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Feb-2021, the patient experienced HEART RATE INCREASED (rapid Heart beat), DYSPNOEA (difficulty breathing) and DIZZINESS (dizziness). At the time of the report, HEART RATE INCREASED (rapid Heart beat), DYSPNOEA (difficulty breathing) and DIZZINESS (dizziness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not provided. Treatment details were not provided.
I received vaccine on Friday 02/19/2021 , Saturday woke up with rash on back and pain under left breast went to doctor 02/23/2021, they prescribed cream Triamcinolone Acetonide Cream 0.5%. then went back Monday 03/08/2021 they prescribed Valacyclovir  gram every  hours  for 21 pills  and Gabapentin for the pain   for what they called shingles .
I have excruciating pain in the souls of both my feet especially in the heel area. It feels like my feet are on fire and it hurts so badly to walk on them.
Patient says injection site is sore but there is more pain under her arm in the armpit area.
I am experiencing right breast pain.   I received this 2nd dose and the 1st dose in my right arm.  The breast pain begin in the middle of the night following the shot.  The pain is about a 2 on the pain scale in is persistent.
Mild headache and fatigue one hour after administration. Nausea to the point of emesis by 1630, headache increased in severity and beginning to chill, visible tremoring, requiring my leave from work before the end of my shift. Sore at injection site by  2000 hrs. site had swollen to the side of a tangerine orange red, hard, tender, the previous injection site from the first vaccine approximately one inch above was also swollen, and red, but the size of a dime stacked 3x. Both injections sites had their own circular indurations, I have never had a reaction to vaccine like this. My arm ached going down to my fingers and up into my neck. My spine ached from the base of the skull to my tailbone, and my hips, but not as severe as the first vaccine reaction.  I was able to move without being brought to tears. The nausea persisted.  The chilling this time brought a low grade fever 99.8.   Unable to work the second day after the vaccine.  Symptoms persist  till Saturday around 1600hrs then completely gone. Reported S/S to Dr. day of  second dose of the vaccine administered.  Advised to continue Tylenol .
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication information provided. No treatment medication information provided.  It was reported that there had been no power outages that would have impacted the Moderna vaccine. However, the Healthcare professional reiterated that because her facility was unable to download the digital data logger, they would need to treat the issue as a temperature excursion. The data logger was unable to download for the months of Dec-2021, Jan-2022, and Feb-2022. They were filling out a temperature excursion assessment with the local Health Authority at that time. It was reported that no adverse reactions were reported by any patient. Reporter confirmed that patients had administered doses while the temperature excursion assessment was ongoing.   This case was linked to MOD-2022-501575 (Patient Link).
Around 2/19-2/20: mildly painful in upper left arm, not at the injection site but more in the region of my triceps.  2/21: slight itchiness in the same region described above  2/22: ~10 days after the 1st vaccine began having red lesions (2) on my left upper arm. Not at the injection site, but the back portion of my arm. Lesions started out painful, firm, red, risen, hot to the touch and  pruritic. Lesions got much larger throughly the day and overnight.
Information has been received from a pharmacy student concerning a 74 year old female patient who on 24-NOV-2007 was vaccinated with Zostavax (Oka/Merck), SQ, 0.65 ml (lot number 658361/1090U). On 25-NOV-2007 the patient developed swelling on the crease of her elbow and numbness from the injection area down to the lower arm. It was reported the patient contacted the pharmacy and physician for medical attention. At the time of reporting, the patient's swelling at crease of elbow and numbness from injection area down to lower arm persisted. There was no product quality complaint. Additional information has been requested. Follow-up information from the pharmacist indicated that in the am on 25-NOV-2007 the patient had numbness on the injection arm especially in the lower arm and thumb. The patient saw the physician on 28-NOV-2007 for enlarged gland in elbow cease. As reported the enlarged gland wasn't bad enough for any medications and her numbness had gotten better. Doctor did not think vaccination hit a nerve, thought maybe susceptible to the vaccine. The doctor was asked about Bell's Palsy, but he did not think this was involved. The patient saw the doctor about the rash (spots) broken out on her chest and upper arms. No medication/ antivirals were prescribed. The pharmacist indicated on 08-JAN-2008 the patient saw a neurologist who ran "nerve testing", all reults were normal. The patient reported the spots on her chest had resolved on their own.
non stop coughing; pain in left arm, pain traveling down down the arm to her hand; brain fog; very uncoordinated; aches; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (non stop coughing), PAIN IN EXTREMITY (pain in left arm, pain traveling down down the arm to her hand), FEELING ABNORMAL (brain fog), COORDINATION ABNORMAL (very uncoordinated) and MYALGIA (aches) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included CARBIDOPA, LEVODOPA (LEVODOPA + CARBIDOPA FAIRMED), CLONIDINE, LEVOTHYROXINE SODIUM (LEVOXYL) and FAMOTIDINE for an unknown indication.    On 25-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Feb-2021, the patient experienced COUGH (non stop coughing), PAIN IN EXTREMITY (pain in left arm, pain traveling down down the arm to her hand), FEELING ABNORMAL (brain fog), COORDINATION ABNORMAL (very uncoordinated) and MYALGIA (aches). The patient was treated with ACETYLSALICYLIC ACID (ASPIRIN (E.C.)) at an unspecified dose and frequency; BENZONATATE (TESSALON PERLE) at an unspecified dose and frequency; PREDNISONE at an unspecified dose and frequency; GUAIFENESIN (MUCINEX) at an unspecified dose and frequency and SALBUTAMOL (ALBUTEROL HFA) at an unspecified dose and frequency. On 12-Mar-2021, PAIN IN EXTREMITY (pain in left arm, pain traveling down down the arm to her hand), FEELING ABNORMAL (brain fog), COORDINATION ABNORMAL (very uncoordinated) and MYALGIA (aches) had resolved. At the time of the report, COUGH (non stop coughing) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
past 42 day mark for her first vaccine; A spontaneous report was received from a consumer concerning herself ,female patient of unspecified age who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced missed dose.  The patient's medical history was not provided. Concomitant product use was not provided by the reporter.  The patient received their first of two planned doses of mRNA-1273 (Batch number: 037A20A) on 28 Jan 2021 for the prophylaxis of COVID-19 infection.   The patient had past 42 day mark for her first vaccination and had missed the second dose.  Treatment information was not provided.   Action taken with mRNA-1273 in response to the event(s) was unknown.  The outcome of the event missed dose was unknown.; Reporter's Comments: This report refers to a case of Product dose omission issue(missed second dose) for mRNA-1273, lot # 037A20A  with no associated Adverse Events.
chills, stomach upset, and muscle aches within 24 hours of administration. Symptoms resolved without intervention.
Had a fever of 102, muscle aches, joint pain, chills, fatigue. This last three days at least. Then about a week later I started getting dizzy and nauseous in the morning. Sometimes it lasted all day, sometimes It didn?t. And I also had intestinal distress. This is still going on to this day. I am due to get the second vaccine on March 31. I am very worried about the second vaccine. I am afraid I?m going to get a lot worse, because most of the vaccine reactions I?ve read about have happened on the second vaccine. Mine was pretty bad on the first one. So I need some help on this. By the way I had COVID-19 on Thanksgiving day.
Patient complained of dizziness, light headedness, double vision, and feeling very shaky approximately 30-45 minutes after receiving vaccine.
Full body pain, migraine, dizziness, severe fatigue, low grade fever, blurry vision for 24+ hours